Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia [Phase 2]

View source ↗

Summary

Phase 2 trial updates the safety, tolerability, PK/PD, and preliminary efficacy of VIT-2763 in beta-thalassemia with non-transfusion-dependent thalassemia; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Non-transfusion-dependent Thalassemia

Drugs mentioned

• VIT-2763

Snippet

Sponsor: Vifor (International) Inc. | Conditions: Beta-Thalassemia, Non-transfusion-dependent Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-14